Related Experiment Video
Updated: Mar 30, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health
Stephen D Persell1, Tiffany Brown2, Ji Young Lee2
1From the Division of General Internal Medicine and Geriatrics, Department of Medicine (S.D.P., T.B., J.Y.L., S.S., M.J.-J., N.R.K., D.W.B.), Center for Primary Care Innovation, Institute for Public Health and Medicine (S.D.P., N.R.K., D.W.B.), Division of Cardiology (D.M.L.-J.), and Department of Preventive Medicine (D.M.L.-J., N.R.K.), Feinberg School of Medicine, Northwestern University, Chicago, IL; Department of Medicine, Stanford University, Stanford, CA (S.S.); North Country Healthcare, Flagstaff, AZ (E.H.); Near North Health Service Corporation, Chicago, IL (T.L., T.S.); Alliance of Chicago Community Health Services, Chicago, IL (T.L., T.S.); and Heartland Health Outreach, Chicago, IL (S.L.). spersell@nm.org.
Background:
Many eligible primary cardiovascular disease prevention candidates are not treated with statins. Electronic health record data can identify patients with increased cardiovascular disease risk.
Methods And Results:
We performed a pragmatic randomized controlled trial at community health centers in 2 states. Participants were men aged ≥35 years and women ≥45 years, without cardiovascular disease or diabetes mellitus, and with a 10-year risk of coronary heart disease of at least 10%. The intervention group received telephone and mailed outreach, individualized based on patients' cardiovascular disease risk and uncontrolled risk factors, provided by lay health workers. Main outcomes included: documented discussion of medication treatment for cholesterol with a primary care clinician, receipt of statin prescription within 6 months, and low-density lipoprotein (LDL)-cholesterol repeated and at least 30 mg/dL lower than baseline within 1 year. Six hundred forty-six participants (328 and 318 in the intervention and control groups, respectively) were included. At 6 months, 26.8% of intervention and 11.6% of control patients had discussed cholesterol treatment with a primary care clinician (odds ratio, 2.79; [95% confidence interval, 2.25-3.46]). Statin prescribing occurred for 10.1% in the intervention group and 6.0% in the control group (odds ratio, 1.76; [95% confidence interval, 0.90-3.45]). The cholesterol outcome did not differ, and the majority of patients did not repeat lipid levels during follow-up.
Conclusions:
Risk communication and lay outreach increased cholesterol treatment discussions with primary care clinicians. However, most discussions did not result in statin prescribing. For outreach to be successful, it should be combined with interventions to encourage clinicians to follow contemporary risk-based cholesterol treatment guidelines.
Clinical Trial Registration:
URL: http://www.clincialtrials.gov. Unique identifier: NCT01610609.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care

